{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-069538","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2022-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.672575+00:00","generated_at":"2026-06-22T05:32:20.151390+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Avra Medical Robotics to acquire CardioVentures in reverse merger; SSI-DE holders to get 95% of stock","bullets":["SSI-DE stockholders to receive 95% of post-merger Avra common stock plus Series A Preferred shares with 51% voting power.","Avra provided $1.44M interim financing to SSI-DE; up to $5M in convertible notes sold to three accredited investors.","Conditions include 1-for-10 reverse stock split, name change to 'SS Innovations, Inc.', and authorized shares increase to 250M.","Dr. Srivastava to assign SSI intellectual property to Avra; current Avra directors to resign except Barry Cohen."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-069538","json":"https://secwatch.observer/filing/0001213900-22-069538.json","markdown":"https://secwatch.observer/filing/0001213900-22-069538.md","text":"https://secwatch.observer/filing/0001213900-22-069538.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/0001213900-22-069538-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/ea168119-8k_avramedical.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T05:32:20.151390+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9ef643568b658d7978bb908837c41bda916acf17","claim":"SS Innovations International, Inc. entered into Merger Agreement with CardioVentures, Inc. and Dr. Sudhir Srivastava (effective 2022-11-07).","evidence_excerpt":"On November 7, 2022, AVRA entered into a definitive Merger Agreement (the “ Merger Agreement ”), by and among AVRA, AVRA-SSI Merger Corporation, a Delaware corporation and wholly-owned subsidiary of AVRA (“ Merger Sub ”), CardioVentures, Inc., a Delaware corporation (“ SSI - DE ”) Dr. Sudhir Srivastava (“ Dr. Srivastava ”), who, through his holding company, owns a controlling interest in SSI-DE.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/0001213900-22-069538-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"CardioVentures, Inc. and Dr. Sudhir Srivastava"},{"label":"Effective","value":"2022-11-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}